Thursday 31 March 2016

Capecitabine, an anti-metabolite for the treatment of colorectal cancer

Capecitabine is a prodrug which gets converted into the chemotherapeutic drug 5-Fluorouracil in the body. 5-fluorouracil is a pyrimidine antagonist. Capecitabine is just one of the many generic oncology products that are available from Taj Accura Pharmaceuticals.
http://www.tajaccura.com/product/capecitabine-tablets-150mg/

What is Capecitabine used for?
Capecitabine is a mainstay of anti-cancer therapy. It is in frequent use for the treatment of various different types of cancer, including:
  • Metastatic colorectal cancer [i]
  • Metastatic breast cancer
  • Stomach cancer and
  • Oesophageal cancer.





How does Capecitabine work?
As we saw earlier, Capecitabine is a prodrug. This means that it is not active in and of itself but only starts to exert its effects after having been converted to the active form of the drug within the body. In this case, the active form is a drug called 5-fluorouracil.
Fluorouracil binds to a particular enzyme known as thymidylate synthase and inhibits its normal activity. Thymidylate synthase is involved in the synthesis of DNA within cells. The mechanism of 5-fluorouracil is referred to as suicide inhibition because the drug binds to the enzyme in an irreversible fashion. [ii]
Essentially, if a patient is given Capecitabine then the first step that occurs is the conversion of capecitabine to 5-fluorouracil. 5-FU will then bind to its target, the thymidylate synthase enzyme, thereby preventing it from manufacturing any additional DNA. The consequence of this is that the cancer cells are no longer capable of dividing so they begin to die off. [iii]

Are there any side effects associated with the use of Capecitabine?
Yes, side effects occur relatively frequently in patients being treated with Capecitabine. The reason for this is that chemotherapeutics are not capable of telling the difference between tumour cells and healthy cells. As a consequence, they will unfortunately kill some of the normal cells.
However, these side effects can be predicted so steps are always taken by the healthcare professionals administering the drug to limit the impact on the patient.
Some of the more common side effects include:
  • Anaemia (low red blood cell count)
  • Nausea and/or vomiting (there are medicines available now to treat this)
  • Hand-Foot Syndrome (pain, swelling and peeling of skin on palms of hands and soles of feet)
  • Loss of appetite and
  • diarrhoea (can be managed by drinking plenty of fluids).
Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with Capecitabine.

How is Capecitabine taken?
Capecitabine tablets are taken within 30 minutes of a meal. They should be swallowed whole with a glass of water. They are normally taken for two weeks followed by a rest period lasting one week. The doctor calculates the required dose on the basis of the body surface area of the patient.
The dose can also change depending on the type of cancer, the weight of the patient and how well their liver and kidneys are functioning. Patients will take regular blood tests during treatment so that their healthcare team can monitor their response to the therapy and ensure their safety.

Conclusion
Capecitabine tablets
are available from Taj Accura Pharmaceuticals at doses of either 150 mg or 500 mg. Please visit www.tajaccura.com for further details.
Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.

Taj Accura Pharmaceuticals are committed to providing affordable pharmaceutical care solutions to health providers and patients globally. Our enthusiastic and highly skilled bi-lingual sales team in English and French are more than welcome to take your queries. We are contactable by emailing info@tajaccura.com, by phone at + 353 (1) 293 1882 or alternatively by fax at + 353 (1) 293 1883
 ___________________________________________________________________________
[i] Rossi, S, ed. (2013). Australian Medicines Handbook (2013 ed.). Adelaide: The Australian Medicines Handbook Unit Trust.
[ii] Longley D. B., Harkin D. P., Johnston P. G. (May 2003). “5-fluorouracil: mechanisms of action and clinical strategies”. Nat. Rev. Cancer 3 (5): 330–8.
[iii] Álvarez, P.; Marchal, J. A.; Boulaiz, H.; Carrillo, E.; Vélez, C.; Rodríguez-Serrano, F.; Melguizo, C.; Prados, J.; Madeddu, R.; Aranega, A. (February 2012). “5-Fluorouracil derivatives: a patent review”. Expert Opinion on Therapeutic Patents 22 (2): 107–123.

Melphalan, a generic oncology product now available from Taj Accura Pharmaceuticals

Melphalan is a cytotoxic drug which belongs to a class of medicines known as alkylating agents.
It is an important component of chemotherapy regimens for the treatment of various different types of cancer.
http://www.tajaccura.com/product/melphalan-50mg-injection-3/

What is Melphalan used for?
Melphalan is used in the treatment of
  • Ovarian Cancer
  • Breast Cancer
  • Multiple Myeloma (cancer of the bone marrow)
  • Neuroblastoma (a childhood cancer that often develops in the adrenal gland) and
  • Rhabdomyosarcoma (a rare cancer of muscle tissue). [i]





How does Melphalan work?
As mentioned earlier, Melphalan is an alkylating agent, a common class of chemotherapeutic medicines. DNA is made up of four different nucleotides, one of which is known as guanine. Melphalan attaches an alkyl group to guanine thereby causing DNA strands to stick together.
The consequence of this is that the affected cells are no longer capable of synthesising DNA. Without this ability, the cells are unable to divide and so they quickly die off.  
Cancerous cells are characterised by their increased speed of cell division. One consequence of this is that they are more likely to be attacked by Melphalan than healthy cells. As we will see in the next section however, the selectivity is not perfect.

Are there any side effects associated with the use of Melphalan?
Yes, there is the potential for patients using Melphalan to develop side effects, just like other chemotherapeutic drugs. However, it should be noted that these side effects are usually predictable so steps can be taken to minimise or prevent them. The effects are almost always reversible.
Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with Melphalan. Some of the more common side effects include:
  • Low blood counts (the decreased production of red and white blood cells in the bone marrow can put patients at risk of picking up a secondary infection. Furthermore, the lower levels of platelets can increase their risk of bleeding)
  • Nausea, vomiting or loss of appetite (these are more severe when using higher doses but there are many medicines now available to control these symptoms)
  • Hair Loss (this is really only a problem when using high doses of melphalan)
  • Mouth ulcers and
  • Loss of fertility.

How is Melphalan given?
Melphalan is available as an injection or as tablets. In the case of the injection, the drug can be given as an infusion into a vein or alternatively, as a perfusion into an artery. This will be done by the patient’s doctor or by another trained health professional, never by the patient themselves.
The patient’s doctor will also decide on what dosage to use and whether to administer the injections or the tablets. Different patients receive different treatments because of the variations in weight, height, age, kidney function and several other parameters.
Do patients undergo monitoring during treatment?
Yes, patients will receive regular check-ups at which time they will undergo tests for their blood count, kidney function, liver function and electrolyte levels. Their healthcare professional will also check to see if they have experienced any side effects.

Conclusion
Melphalan Hydrochloride Injections
to be used in the treatment different types of cancer are available from Taj Accura Pharmaceuticals at a dose of 50 mg. Taj Accura also provide Melphalan tablets at a dose of 2 mg. Please visit www.tajaccura.com for further details.
Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.

Taj Accura Pharmaceuticals are committed to providing affordable pharmaceutical care solutions to health providers and patients globally. Our enthusiastic and highly skilled bi-lingual sales team in English and French are more than welcome to take your queries. We are contactable by emailing info@tajaccura.com, by phone at + 353 (1) 293 1882 or alternatively by fax at + 353 (1) 293 1883
________________________________________________________________________________
[i] Facon T, Mary JY, Hulin C et al. (October 2007). “Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial”. Lancet 370 (9594): 1209–18.

Hydroxyurea, an anti-metabolite for the treatment of Sickle Cell disease

Hydroxyurea is a commonly used anti-cancer drug that is now available from Taj Accura Pharmaceuticals.
Hydroxyurea, an anti-metabolite for the treatment of Sickle Cell disease

What is Hydroxyurea used for?
Hydroxyurea is used in the treatment of various different disorders including:
  • Sudden chest pain caused by Sickle Cell Disease (This is a blood disorder which causes the red blood cells to adopt an irregular shape. The patient develops anaemia as well as chest pains on account of the blood cells getting stuck in their blood vessels). [i]
  • Chronic myeloid leukaemia (this is a disease of the bone marrow that causes patients to produce excess amounts of white blood cells) [ii]
  • Head and neck cancer
  • Ovarian cancer (especially when the ovarian cancer has failed to respond to first-line therapy) and
  • Polycythemia vera and essential thrombocytosis (rare disorders of the bone marrow). [iii]



How does Hydroxyurea work?
When used for the treatment of cancer, hydroxyurea stops cancer cells from growing by inhibiting a particular enzyme known as RNR. The cancer cells want to make more DNA as they replicate but hydroxyurea destroys the building blocks that the cells need for this. This makes cell division much more difficult so the tumour cells stop growing and start to die off.
When used to treat pain caused by sickle-cell disease, hydroxyurea increases the amount of haemoglobin in the blood. Scientists do not yet fully understand the precise mechanism. [iv]

Are there any side effects associated with the use of Hydroxyurea?
Yes, patients being treated with Hydroxyurea will tend to experience side effects. This is because chemotherapeutic drugs are not able to recognise the difference between tumour cells and healthy cells. The unfortunate consequence of this is that they will kill some of the normal cells.
However, these side effects can be predicted so steps are always taken by the healthcare professionals administering the drug to limit the impact on the patient.
Some of the more common side effects include:
  • An increased risk of infection (on account of the drug bringing about a decrease in the patient’s white blood cells, the cells that normally fight off infections)
  • Anaemia (as the drug can also reduce the number of red blood cells)
  • Nausea, vomiting and/or loss of appetite (there are medicines available now to treat this)
  • Mild loss of hair
  • Discolouration of the skin and/or the nails.
Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with Hydroxyurea.

How is Hydroxyurea taken?
Hydroxyurea tablets are taken orally. It is possible to dissolve them in water.
The doctor calculates the required dose which is different for each patient. The dose depends on the type of cancer, the weight of the patient and how well their liver and kidneys are functioning.
Patients will take regular blood tests during treatment so that their healthcare team can monitor their response to the therapy and ensure their safety.

Conclusion
Hydroxyurea tablets
are available from Taj Accura Pharmaceuticals at doses of either 100 mg or 1000 mg. Please visit www.tajaccura.com for further details.
Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.
Taj Accura Pharmaceuticals are committed to providing affordable pharmaceutical care solutions to health providers and patients globally. Our enthusiastic and highly skilled bi-lingual sales team in English and French are more than welcome to take your queries. We are contactable by emailing info@tajaccura.com, by phone at+ 353 (1) 293 1882 or alternatively by fax at + 353 (1) 293 1883

_________________________________________________________________________________
[i] Lanzkron S, Strouse JJ, Wilson R, et al (2008).”Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease”. Ann. Intern. Med. 148 (12): 939–55.
[ii] Dalziel K, Round A., Stein K, Garside R, Price A, (2004). “Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: A systematic review and economic analysis”. Health technology assessment (Winchester, England) 8 (28): iii, ii1–120.
[iii] Tefferi, A and Barbui T (2015). Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk‐stratification and management. American Journal of Hematology, 90(2), 162-173.
[iv] Platt OS (2008). “Hydroxyurea for the treatment of sickle cell anemia”. N. Engl. J. Med. 358 (13).

Tuesday 29 March 2016

Gemcitabine, an anti-metabolite for the treatment of lung cancer

Gemcitabine is an anti-metabolite drug frequently used in chemotherapy. It is just one of the many generic oncology products that are available from Taj Accura Pharmaceuticals.
http://www.tajaccura.com/product/gemcitabine-powder-for-solution-for-infusion-injection-usp-200mg-1000mg/

What is Gemcitabine used for?
Gemcitabine is in regular use for the treatment of various different types of cancer, including:
  • Non-small cell lung cancer
  • Metastastic breast cancer
  • Pancreatic cancer
  • Ovarian cancer and
  • Bladder cancer
Gemcitabine is often used in combination with another anti-cancer drug such as paclitaxel, cisplatin or carboplatin in order to maximise their effects.



How does Gemcitabine work?
Gemcitabine is structurally similar to a compound in our cells called cytidine.[i] Cytidine is a nucleoside and is needed for the replication of DNA during cell division. When a patient is given gemcitabine, the cancerous cells in their body mistakenly think that the drug is actually cytidine. As a result, they become incapable of dividing correctly and will stop growing. This eventually leads to the death of the tumour cells.[ii]
Additionally, gemcitabine can bind to an enzyme known as RNR. When this takes place, the enzymes become permanently inactivated. The end result of this process is essentially the same as before i.e. the cells cannot replicate their DNA so they die off. [iii]

Are there any side effects associated with the use of Gemcitabine?
Yes, side effects occur relatively frequently in patients being treated with Gemcitabine. The reason for this is that chemotherapeutics are not capable of telling the difference between tumour cells and healthy cells. As a consequence, they will unfortunately kill some of the normal cells.
However, these side effects can be predicted in advance so steps are always taken by the healthcare professionals administering the drug to limit the impact on the patient.
Some of the more common side effects include:
  • Anaemia (low red blood cell count)
  • Increased risk of infection (due to a low white blood cell count)
  • Flu-like symptoms (headache, fatigue, fever and muscle aches)
  • Nausea, vomiting and/or loss of appetite (there are many medicines now available to alleviate these symptoms) and
  • Skin rash.
Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with Gemcitabine.

How is Gemcitabine taken?
Gemcitabine is always given as an infusion through a vein. The doctor calculates the required dose on the basis of the body surface area of the patient.
The dose can also change depending on the type of cancer, the weight of the patient and how well their liver and kidneys are functioning. Patients will take regular blood tests during treatment so that their healthcare team can monitor their response to the therapy and ensure their safety.

Conclusion
Gemcitabine powder for solution for infusion is
available from Taj Accura Pharmaceuticals at doses of either 200 mg or 1000 mg. Please visit www.tajaccura.com for further details.
Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.

Taj Accura Pharmaceuticals are committed to providing affordable pharmaceutical care solutions to health providers and patients globally. Our enthusiastic and highly skilled bi-lingual sales team in English and French are more than welcome to take your queries. We are contactable by emailing info@tajaccura.com, by phone at + 353 (1) 293 1882 or alternatively by fax at + 353 (1) 293 1883

_________________________________________________________________________
[i] Mini E, Nobili S, Caciagli B, Landini I and Mazzei T. (2006). Cellular pharmacology of gemcitabine. Annals of Oncology, 17 (suppl 5), v7-v12.
[ii] Plunkett W, Huang P, Xu YZ, Heinemann V, Grunewald R and Gandhi V. (1995, August). Gemcitabine: metabolism, mechanisms of action, and self-potentiation. In Seminars in oncology (Vol. 22, No. 4 Suppl 11, pp. 3-10).
[iii] N Cerqueira, PA Fernandes and MJ Ramos (2007). “Understanding ribonucleotide reductase inactivation by gemcitabine”. Chemistry: A European Journal 13 (30): 8507–15.

Imatinib, an Enzyme Inhibitor used to treat Leukaemia

Imatinib is a tyrosine kinase inhibitor (TKI). This class of anti-cancer drugs inhibit the action of particular enzymes known as tyrosine kinases within the body. Imatinib is one of many generic oncology products available from Taj Accura Pharmaceuticals.
 http://www.tajaccura.com/product/tyronib-imatinib/

What is Imatinib used for?
Imatinib is mainly used for the treatment of:
  • Chronic Myeloid Leukaemia (In particular a form of CML that is said to be ‘Philadelpha Chromosome positive’). [i]
  • Relapsed or refractory Acute Lymphoblastic Leukaemia (again this is particularly for ALL that is Philadelphia Chromosome positive).
  • Myeloproliferative disease (these are a range of conditions in which the blood cells grow at abnormal rates within the bone marrow).
  • Gastrointestinal tumours.





How does Imatinib work?
Imatinib is known as a targeted therapy because it has been developed to be much more specific for cancer cells than healthy cells.[ii] It inhibits the actions of the tyrosine kinase enzymes. These proteins are used as chemical messengers by cells in our bodies. They tell other cells when they should start to grow. This is obviously of relevance to cancer which involves uncontrolled cell growth.
This cell growth arises when the tyrosine kinases accidentally get permanently activated, such that cells begin to grow and divide much faster than normal.
When a patient is given Imatinib, the drug binds to the receptor and prevents it from getting activated. Consequently, the receptor is no longer capable of telling cells to continue dividing so tumour growth is either slowed or stopped completely.[iii]

Are there any side effects associated with the use of Imatinib?
Yes, as with other chemotherapeutics, there is a risk of side effects developing in patients being treated with Imatinib. Having said that, Imatinib is actually a safer drug that many of the older chemotherapeutics because it is a targeted therapy. In other words, it mainly leaves healthy cells alone and only goes after the cancerous cells.
Everyone reacts differently but examples of potential side effects include:
  • Nausea and vomiting (there are now effective medications available to manage this)
  • Diarrhoea (to avoid complications, patients should remain properly hydrated)
  • Reduced blood counts, potentially leading to an increased risk of infection
  • Swelling of the hands, feet and face
  • Itchy skin and rashes.
Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with Imatinib.

How is Imatinib given?
Imatinib is given as a tablet. Patients usually take their Imatinib tablet with a meal in order to reduce the risk of stomach irritation. They are advised to swallow them whole with a glass of water. The exact dose and timing will differ between patients, according to the instructions of their doctor.

Conclusion
Imatinib Hydrochloride
tablets to be used in the treatment of non-small cell lung cancer are available from Taj Accura Pharmaceuticals at doses of 100 mg or 400 mg.
Please visit www.tajaccura.com for further details.
Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.
Taj Accura Pharmaceuticals are committed to providing affordable pharmaceutical care solutions to health providers and patients globally. Our enthusiastic and highly skilled bi-lingual sales team in English and French are more than welcome to take your queries. We are contactable by emailing info@tajaccura.com by phone at + 353 (1) 293 1882 or alternatively by fax at + 353 (1) 293 1883

___________________
[i] Goldman JM, Melo JV (October 2003). “Chronic myeloid leukaemia – advances in biology and new approaches to treatment”. N. Engl. J. Med. 349 (15): 1451–64.
[ii] Fausel, C (2007). Targeted chronic myeloid leukaemia therapy: Seeking a cure. Am J Health Syst Pharm 64, S9-15.
[iii] Deininger MW, Druker BJ (September 2003). “Specific targeted therapy of chronic myelogenous leukaemia with imatinib”. Pharmacol. Rev. 55 (3): 401–23.

Friday 25 March 2016

Methotrexate Injection, An Anti-folate with Anti-Cancer and Immunosuppressant properties



Methotrexate Injection, An Anti-folate with Anti-Cancer and Immunosuppressant properties

Methotrexate is a member of a therapeutic class of medicines referred to as Anti-metabolite medication because of the impact they have on cell growth within the body and is more specifically classified as an Anti-folate as it’s mechanism of action involves the inhibition of folic acid metabolism[1]. It also classified as an immunosuppressant owing to its ability to reduce immune system activity making it useful in treating autoimmune conditions. Methotrexate is available from Taj Accura Pharmaceuticals in a variety of dosage forms and strengths. It is available in:
·         Tablet dosage form at strengths of 2.5 mg, 7.5 mg and 10 mg
·         Injections at strengths of 5 mg per 2 mL, 50 mg per 2 mL, 100 mg per 2 mL and as 1000mg per 2mL
This article will focus specifically on the injectable form.






What is Methotrexate Injection used for?
Methotrexate injection is used either as a mono-therapy or a poly-therapy in the treatment of a number of different types of cancer as a result of the large doses of Methotrexate which can be delivered by utilising the injection dosage form. Types of cancer it used to treat include[2]:
·         Breast cancer, Uterine cancer
·         Head and Neck cancer
·         Lung cancer
·         Blood cancer, Bone cancer
·         Lymph node cancer
When used in this capacity, Methotrexate is considered an anti-neoplastic medicine and works via interfering with an enzyme and thereby interfering with cancer cell growth.
Methotrexate injection also has a number of other uses as an immunosuppressant, including being used in severe psoriasis to control symptoms which have failed to respond to earlier treatment options, to treat adults with rheumatoid arthritis and children with polyarticular juvenile idiopathic arthritis.










How does Methotrexate Injection work?
Methotrexate acts via the inhibition of the enzyme Dihydrofolate reductase by virtue of the fact that it possesses a higher affinity for the enzyme than the endogenous dihydrofolate[3]. Intracellular tetrahydrofolate is depleted as a result. The inhibition Dihydrofolate reductase prevents Tetrahydrofolate generation which therefore interferes with the synthesis of Thymidylate.
The folate transport system takes Methotrexate up into cells and converts it to the polyglutamate form. Normal cells which are affected by high doses of the medication may be “saved” by Folinic acid

Are there any side effects associated with the use of Methotrexate Injection?
Yes, as with all medication there is a possibility that the patient may experience side effects. Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with Methotrexate.
Methotrexate is a very toxic medicine and is capable of causing serious illness or even death so any side effects experienced should be reported to a doctor.

How is Methotrexate Injection given?
Methotrexate injections may be administered via a number of different routes including intravenously (into a vein), intramuscularly (into a muscle), intraarterially (into an artery) or even intrathecally (into the spine). It is also given by intravenous infusion (by drip)
The dose of Methotrexate varies with the condition being treated. A doctor will work out the correct dose of Methotrexate Injection for the patient and how often it must be given.
Before initialising Methotrexate therapy it is important that the doctor carries out blood tests in order to obtain cell counts and assess both hepatic and renal function. A chest x-ray is sometimes also carried out. Further testing may be required as therapy progresses

Conclusion
Methotrexate Injections, for the treatment of a number of different types of Cancer and Rheumatoid Arthritis as well as management of Severe Psoriasis, are available from Taj Accura Pharmaceuticals at strengths of 5 mg per 2 mL, 50 mg per 2 mL, 100 mg per 2 mL and as 1000mg per 2mL. Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.
Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.
Taj Accura Pharmaceuticals are committed to providing affordable pharmaceutical care solutions to health providers and patients globally. Our enthusiastic and highly skilled bi-lingual sales team in English and French are more than welcome to take your queries. We are contactable by emailing info@tajaccura.com by phone at + 353 (1) 293 1882 or alternatively by fax at + 353 (1) 293 1883. Please also visit www.tajaccura.com for further details on our products and services.



[1] Rossi S. Australian Medicines Handbook: Adelaide: The Australian Medicines Handbook Unit Trust.; 2013.
[2] MayoClinic. Methotrexate (Injection Route, Subcutaneous Route) Mayo Foundation for Medical Education and Research2015.
[3] HP Rang MD, JM Ritter, RJ Flower, G Henderson. Rang and Dale's Pharmacology 7th Edition: Elsevier; 2012.

AIZEN, emergency treatment of hypoproteinaemia and burns



AIZEN, emergency treatment of hypoproteinaemia and burns

AIZEN® (Human Albumin 20% IV) is an intravenous solution containing human albumin, a colloid, administered via infusion. There are 20 g of human plasma protein present in 100 mL of human albumin solution offered by Taj Accura Pharmaceuticals, at least 95% of which is human albumin.
Human albumin for medical use can be used to replace lost fluid and restore blood volume in surgery, burns and trauma. It has frequently been utilised in conditions where albumin loss is problem, liver disease with ascites in particular.

The indications which human albumin has been licenced for include emergency treatment of conditions where restoring blood volume is urgent such as hypoproteinaemia and burns.
AIZEN® (Human Albumin 20% IV) intravenous solution for infusion are one of the many generic medicinal products that are available from Taj Accura Pharmaceuticals.



How does AIZEN work?
·         AIZEN is intravenously infused in order to restore and maintain circulating blood volume.
·         Conditions in which low blood volume such as hypoproteinaemia and burns are a problem require use of a colloid such human albumin in AIZEN (Human Albumin 20% IV) intravenous solution for infusion.

How should AIZEN be taken?
·         AIZEN® (Human Albumin 20% IV) intravenous solution for infusion is usually administered in a hospital by a healthcare professional such as a doctor or nurse.
·         It can be directly administered intravenously or after dilution with 0.9% sodium chloride solution.
·         The dosage and frequency of administration of AIZEN is decided by the patient’s doctor and is dependent on their size, illness and how much fluid and protein has been lost. This will be decided based on calculations to obtain the correct levels.

Are there any side effects associated with the use of AIZEN?
Yes, as with all medication there is a possibility that the patient may experience side effects but not everyone experiences them. Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with AIZEN tablets.
Very rarely, severe reactions such as shock may occur. If this happens the infusion will be stopped and the appropriate treatment will be started.
 
Conclusion
AIZEN (Human Albumin 20% IV) intravenous solution for infusion, for the treatment of hypoproteinaemia and burns, is available from Taj Accura Pharmaceuticals .

*Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medications.

Taj Accura Pharmaceuticals are committed to providing affordable pharmaceutical care solutions to health providers and patients globally. Our enthusiastic and highly skilled bi-lingual sales team in English and French are more than welcome to take your queries. We are contactable by emailing info@tajaccura.com by phone at + 353 (1) 293 1882 or alternatively by fax at + 353 (1) 293 1883. Please also visit www.tajaccura.com for further information on our products and services.

Mitomycin for treatment of adenocarcinoma





 Mitomycin for treatment of adenocarcinoma
Mitomycin is an anti-cancer antibiotic available from Taj Accura Pharmaceuticals. It is derived from a soil fungus known as Streptomyces and has become an important component of various chemotherapy regimens[i]http://www.tajaccura.com/product/mitomycin-injection-usp-2mg-10mg-20mg-40-mg/


What is Mitomycin used for?
Mitomycin is used in the treatment of
  • Adenocarcinoma of the stomach
  • Adenocarcinoma of the pancreas
  • Non-small cell lung cancer
  • Breast cancer and
  • Colon cancer.



How does Mitomycin work?
Cancerous cells divide faster than normal cells and unlike normal cells, they do not die off when the body tells them to. Mitomycin counteracts this and force the cells to stop growing and die off. It does this by attaching a certain chemical group known as an alkyl group to the DNA. DNA is made up of four different nucleotides, one of which is known as guanine. Mitomycin places the alkyl group onto this guanine nucleotide and this causes the strands of DNA to become sticky and bind together[ii].
The consequence of this is that the cancerous cells that contain the DNA strands are damaged in such a way that they become incapable of dividing. As a result, the cells die off. This process is referred to as apoptosis.

Are there any side effects associated with the use of Mitomycin?
Yes, patients using Mitomycin may develop side effects because the drug is not perfectly selective for cancer cells and can damage healthy cells as well. However, it should be noted that these side effects are usually predictable so steps can be taken to minimise or prevent them. The effects are almost always reversible.
Patients are advised to contact their doctor, pharmacist or nurse if they have any questions regarding treatment with Mitomycin. Some of the more common side effects include:
  • Low blood counts (the decreased production of red and white blood cells in the bone marrow can put patients at risk of picking up a secondary infection. Furthermore, the lower levels of platelets can increase their risk of bleeding)
  • Nausea, vomiting or loss of appetite (these are more severe when using higher doses but there are many medicines now available to control these symptoms)
  • Mouth sores and
  • Fatigue.
How is Mitomycin given?
Mitomycin is typically given as an injection or an infusion into a vein. This will be done by the patient’s doctor or by another trained health professional, never by the patient themselves.
The patient’s doctor will also decide on what dosage to use and whether to administer the injections or the tablets. Different patients receive different treatments because of the variations in weight, height, age, kidney function and several other parameters.

Do patients undergo monitoring during treatment?
Yes, patients will receive regular check-ups at which time they will undergo tests for their blood count, kidney function, liver function and electrolyte levels. Their healthcare professional will also check to see if they have experienced any side effects.

Conclusion
Mitomycin Injections
to be used in the treatment of cancer are available from Taj Accura Pharmaceuticals at doses of 2 mg, 5 mg, 10 mg, 20 mg and 40 mg. Please visit www.tajaccura.com for further details.
Always remember to consult your Doctor or Healthcare Professional if you have any questions about your own health or medication


[i] Danshiitsoodol N, de Pinho CA, Matoba Y, Kumagai T, Sugiyama M (2006). "The mitomycin C (MMC)-binding protein from MMC-producing microorganisms protects from the lethal effect of bleomycin: crystallographic analysis to elucidate the binding mode of the antibiotic to the protein". J Molec Biol 360 (2): 398–408.

[ii] Tomasz, Maria (September 1995). Mitomycin C: small, fast and deadly (but very selective). Chemistry and Biology 2 (9): 575–579.